Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Overcoming some Limiting Factors in Tumour Immunotherapy

British Journal of Cancer volume 28, pages 1–5 (1973)Cite this article

Abstract

Immunotherapy using rat 7s antibodies against plasmacytoma 5563 in C3H mice has been measured carefully. Prior adsorption of antibodies with normal mouse tissues, and supplements of co-optable non-immunized macrophages and lymphocytes enhanced the scope of immunotherapy against established tumours. It is suggested that available co-optable lymphocytes and macrophages are imporant limiting factors in tumour immunotherapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Authors
  1. O Fakhri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J R Hobbs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fakhri, O., Hobbs, J. Overcoming some Limiting Factors in Tumour Immunotherapy. Br J Cancer 28, 1–5 (1973). https://doi.org/10.1038/bjc.1973.64

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1973.64

Search

Advanced search

Quick links